Lisapharma Spa wins over €2 million through the FISA 2022 call

Lisapharma Spa wins over €2 million through the FISA 2022 call

Lisapharma Spa wins over €2 million through the FISA 2022 call 1124 446 bluegreenstrategy

FISA 2022

Lisapharma is a pharmaceutical company specialized in the production of sterile injectable medicines. With our support, and in collaboration with the University of Naples Federico II, it won the call of the Italian Fund for Applied Sciences (FISA), securing over €2 million in funding.

The pharmaceutical company Lisapharma operates both in Italy and abroad, holding a range of marketing authorizations for medicinal products. It also acts as a qualified contract manufacturer for Italian companies and multinational corporations.


About the project

Lisapharma, in collaboration with the University of Naples “Federico II” – Department of Pharmacy, submitted a project to the FISA call for the development of a pharmacological product for the treatment of high-grade gliomas, using brain-targeted nanomedicine based on zoledronic acid.

Back to top